Eisai Co., Ltd v. Glenmark Pharmaceuticals Limited

Court

District Court, D. Delaware (D. Del.)
Official Court Website →

Assigned judge

Leonard P. Stark · 3,682 cases in index

Docket number

1:19-cv-01214

Cause

35:271 Patent Infringement
35 U.S.C. § 271 — Patent infringement

Nature of suit

835 Patent - Abbreviated New Drug Application(ANDA)
Hatch-Waxman patent disputes over a generic-drug (ANDA) application.

Jurisdiction

Federal Question

Jury demand

None

Date filed

06/26/2019

Date terminated

08/26/2019

1,113 Patent - ANDA cases in this court are indexed here.

Parties

• plaintiff · Eisai Co., Ltd · 30 cases
• defendant · Glenmark Pharmaceuticals Limited · 12 cases

Part of a Larger Litigation Pattern

This is one of 13 Patent - ANDA cases in our index naming Glenmark Pharmaceuticals Limited — a possible mass-tort or coordinated-litigation cluster.

• Astellas US LLC v. Glenmark Pharmaceuticals Limited
  District Court, D. DelawareFiled 04/15/2020
• Bausch Health Ireland Limited v. Glenmark Pharmaceuticals Limited
  District Court, D. New JerseyFiled 06/28/2019
• Pfizer Inc v. Glenmark Pharmaceuticals Limited
  District Court, D. DelawareFiled 06/26/2019
• Bausch Health Ireland Limited v. Glenmark Pharmaceuticals Limited
  District Court, D. New JerseyFiled 05/01/2019
• Delcor Asset Corporation v. Glenmark Pharmaceuticals Limited
  District Court, D. DelawareFiled 03/26/2018
• Delcor Asset Corporation v. Glenmark Pharmaceuticals Limited
  District Court, D. DelawareFiled 11/15/2017

About Patent - ANDA Lawsuits

ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

Frequently Asked Questions

What is Eisai Co., Ltd v. Glenmark Pharmaceuticals Limited?

Eisai Co., Ltd v. Glenmark Pharmaceuticals Limited is a federal patent - anda lawsuit filed on 06/26/2019 in the District Court, D. Delaware. The case was terminated on 08/26/2019. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

What type of case is this?

It is classified as “Patent - ANDA” under the federal nature-of-suit system. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

What court is the case in?

The case is in the District Court, D. Delaware, docket number 1:19-cv-01214.

When was the case filed?

Eisai Co., Ltd v. Glenmark Pharmaceuticals Limited was filed on 06/26/2019. It was terminated on 08/26/2019.

What law is the case brought under?

The docket lists the cause as 35 U.S.C. § 271 — Patent infringement.